BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4670459)

  • 1. [Action of a guinea pig serum asparaginase preparation on normal and leukemic mouse lymphocytes].
    Kastrikin NF
    Patol Fiziol Eksp Ter; 1972; 16(5):79-80. PubMed ID: 4670459
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of endotoxin in commercial L-asparaginase preparations by complement fixation and separation by chromatography.
    Loos M; Vadlamudi S; Meltzer M; Shifrin S; Borsos T; Goldin A
    Cancer Res; 1972 Nov; 32(11):2292-6. PubMed ID: 4563138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic effect of L-asparaginase].
    Rakowska-Wódz A; Szyszka K; Abucewicz A
    Wiad Lek; 1970 Jan; 23(2):117-20. PubMed ID: 4985374
    [No Abstract]   [Full Text] [Related]  

  • 4. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
    Capizzi RL; Summers WP; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():302-11. PubMed ID: 5289422
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of a benign virus upon mouse leukemia during asparaginase therapy.
    Riley V
    Pathol Biol (Paris); 1970; 18(15):757-64. PubMed ID: 4917552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electron microscopic observations on the effect of L-asparaginase at transplanted leukemias of the mouse].
    Voigt WH; Grundmann E; Bierling R
    Beitr Pathol Anat; 1970; 140(2):237-55. PubMed ID: 5418958
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 9. Clusters of ribosomes in lymphoma cells 6C3HED-OG of mice given guinea pig serum.
    Coppola A
    Boll Soc Ital Biol Sper; 1974 May; 50(9):595-9. PubMed ID: 4447755
    [No Abstract]   [Full Text] [Related]  

  • 10. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.
    Vadlamudi S; Krishna B; Reddy VV; Goldin A
    Cancer Res; 1973 Sep; 33(9):2014-9. PubMed ID: 4725366
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors influencing the therapeutic activity of L-asparaginase (NSC 109229) in leukemic (L5178Y) mice.
    Vadlamudi S; Padarathsingh M; Waravdekar VS; Goldin A
    Cancer Res; 1970 May; 30(5):1467-72. PubMed ID: 5426950
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive action of L-asparaginase.
    Alexander P
    Proc R Soc Med; 1972 Mar; 65(3):265-6. PubMed ID: 5083314
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction and characteristics of resistance to L-asparaginase (NSC-109229) in mouse leukemia L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Chemother Rep; 1971 Apr; 55(2):115-21. PubMed ID: 5118682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of synthesis of protein and nucleic acid in mouse and human leukemia cells by L-asparaginase in vitro].
    Benvenisty DS
    Harefuah; 1972 Jan; 82(2):68-70. PubMed ID: 4673650
    [No Abstract]   [Full Text] [Related]  

  • 15. [L-asparaginase--first specific cytostatic].
    Marquardt H
    Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
    Nervi C; Casale C; Cortese M
    Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical and genetic aspects of the use of L-asparaginase as an antileukemic factor].
    Medvedev ZhA
    Usp Sovrem Biol; 1971; 71(2):208-19. PubMed ID: 4935597
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R; Dolowy WC
    Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultrastructural changes in murine leukemia cells exposed to l-asparaginase in vitro.
    Williams AO
    Am J Clin Pathol; 1970 Oct; 54(4):658-64. PubMed ID: 5528478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.